Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2001 | |
| Cash Flows From Operating Activities | |
| Net Income | -6,800 |
| Depreciation Amortization | 3,475 |
| Accounts receivable | 341 |
| Accounts payable and accrued liabilities | -1,461 |
| Other Working Capital | -3,916 |
| Other Operating Activity | 872 |
| Operating Cash Flow | $-7,489 |
| Cash Flows From Investing Activities | |
| PPE Investments | -372 |
| Investing Cash Flow | $-372 |
| Cash Flows From Financing Activities | |
| Debt Issued | 17,500 |
| Debt Repayment | -6,500 |
| Other Financing Activity | -2,603 |
| Financing Cash Flow | $8,397 |
| Beginning Cash Position | 7,000 |
| End Cash Position | 7,536 |
| Net Cash Flow | $536 |
| Free Cash Flow | |
| Operating Cash Flow | -7,489 |
| Capital Expenditure | -520 |
| Free Cash Flow | -8,009 |